R&D Costs For Cancer Drugs Are Likely Much Less Than Industry Claims, Study Finds
Industry says it costs about $2.7 billion to bring a cancer drug to market. But oncologists who ran the numbers put the average closer to $650 million. Drugs are priced way too high, the doctors say.
Cancer drugs cost far less to develop than industry-backed research asserts, an analysis published Monday asserts. Research and development costs are a major reason that drug companies justify high prices, so this dispute has a direct bearing on the cost of medical care.
The , published in the current issue of , concludes that it costs, on average, $650 million to develop a new cancer drug. The authors add in another $100 million or so to
